In terms of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, Jubilant Pharmova has enclosed a confirmation Certificate for the quarter ended on June 30, 2026 received from Alankit Assignments, Registrar and Share Transfer Agent of the Company.
The above information is a part of company’s filings submitted to BSE.